Altimmune Inc (ALT)

SG&A Expense Growth

-5.94%

Quarterly · Period ending:

ALT logo

ALT SG&A Expense Growth

Latest reported-5.94%
ALT Quarterly SG&A Growth (QoQ) (0.00% → -5.94%)
High-resolution chart · PNG

ALT sg&a expense growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Altimmune Inc SG&A Expense Growth — Quarterly
Period endingSG&A Expense Growth
-5.9364%
-23.3873%
78.0149%
3.7428%
-5.0392%
17.7407%
2.4351%
-11.1886%
5.3276%
22.6223%
-4.0319%
-5.1681%
5.0541%
19.0802%
-15.2939%
1.8594%
-0.384%
17.2094%
-9.1193%
13.5829%
-4.2397%
-7.0752%
-2.5664%
65.8015%
9.1529%
15.7381%
-7.9006%
-1.9785%
8.0008%
-14.6057%
23.2311%
-33.0694%
19.8574%
53.5909%
-47.5517%
69.3363%
-44.4182%
-37.5713%
39.2193%
158.7987%
20.2869%
22.2906%
-20.7343%
-32.3325%
-17.1611%
-16.2405%
-17.8701%
31.9234%
-9.619%
-41.5443%
12.0882%
75.1745%
2.3219%
-13.1415%
-19.8662%
17.817%
-5.7108%
10.0669%
-18.4098%
-3.6994%
-30.9795%
-8.3659%
69.6293%
-22.9009%
-22.601%
-19.8639%
6.7568%
40.9538%
-14.181%
8.5297%
-1.2831%
-7.1678%
10.5869%
-11.3354%
67.4723%
0%
-100%
-42.0897%
55.1471%
1.5592%
-20.0388%
35.2012%
87.7955%
0%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.